Lifevantage (NASDAQ:LFVN) Stock Passes Below 200-Day Moving Average – Should You Sell?

Lifevantage Corporation (NASDAQ:LFVN) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $8.19 and traded as low as $4.49. Lifevantage shares last traded at $4.59, with a volume of 173,327 shares changing hands.

Wall Street Analysts Forecast Growth

Several analysts have commented on LFVN shares. Lake Street Capital reiterated a “buy” rating on shares of Lifevantage in a research note on Thursday, February 5th. Loop Capital set a $5.00 price target on Lifevantage in a report on Thursday, February 5th. Wall Street Zen downgraded Lifevantage from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Lifevantage in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $5.00.

Lifevantage Stock Down 5.4%

The company has a market cap of $58.72 million, a P/E ratio of 7.65 and a beta of 0.33. The company has a fifty day moving average of $5.78 and a 200 day moving average of $8.19.

Lifevantage (NASDAQ:LFVN) last posted its earnings results on Wednesday, February 4th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.07). The firm had revenue of $48.93 million during the quarter, compared to the consensus estimate of $54.40 million. Lifevantage had a net margin of 3.74% and a return on equity of 29.59%. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a yield of 3.9%. The ex-dividend date is Monday, March 2nd. Lifevantage’s payout ratio is 30.00%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Capital Management Corp VA boosted its stake in shares of Lifevantage by 3.4% during the 4th quarter. Capital Management Corp VA now owns 2,134,574 shares of the company’s stock worth $13,149,000 after acquiring an additional 70,398 shares during the last quarter. Renaissance Technologies LLC raised its holdings in Lifevantage by 8.3% in the 4th quarter. Renaissance Technologies LLC now owns 922,918 shares of the company’s stock worth $5,685,000 after purchasing an additional 70,900 shares during the period. Wasatch Advisors LP raised its holdings in Lifevantage by 6.6% in the 2nd quarter. Wasatch Advisors LP now owns 446,341 shares of the company’s stock worth $5,838,000 after purchasing an additional 27,765 shares during the period. Geode Capital Management LLC lifted its position in Lifevantage by 106.1% during the second quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock valued at $3,210,000 after purchasing an additional 126,274 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in Lifevantage by 305.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 200,222 shares of the company’s stock valued at $1,233,000 after purchasing an additional 150,785 shares during the period. 35.32% of the stock is currently owned by institutional investors.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.